You might be interested in
-
Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri (SF6)Laurence Mulard
-
Glycoconjugates and use thereof as vaccines against Shigella flexneri serotype 3a and XLaurence Mulard
-
Protected tetrasaccharides, their preparation and their use in the synthesis of bacterial oligosaccharidesLaurence Mulard
-
Plague vaccineChristian Demeure
-
Docking method based on saturation transfer difference NMR data, and means for its implementation WO 2019/011987Nadia Izadi-Pruneyre
-
Biomarkers signature(s) for the prevention and early detection of gastric cancerEliette Touati
-
Dendritic cells and adaptive immunityPierre Guermonprez
-
Structural biology of infectious diseasesPablo Guardado-Calvo
-
Translational ImmunologyDarragh Duffy
-
Human Disease Models core facilityMathilde Dusseaux
-
Institut Pasteur-TheraVectys Joint LaboratoryPierre Charneau
-
Human and Artificial PerceptionKeith Doelling